Compounds > 2,2'-dithiodiethanesulfonic acid
Page last updated: 2024-08-24

2,2'-dithiodiethanesulfonic acid and cysteine

2,2'-dithiodiethanesulfonic acid has been researched along with cysteine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hausheer, F; Murphy, M; Pendyala, L; Schwartz, G; Smith, P; Zdanowicz, J1
Bast, A; Boven, E; Hausheer, FH; Torun, E; van der Vijgh, WJ; Verschraagen, M1
Ayala, PY; Chen, S; Chen, X; Hausheer, FH; Huang, Q; Jair, KW; Kochat, H; Parker, AR; Petluru, PN; Shanmugarajah, D1
Bodalia, A; Cutler, MJ; Freeman, DJ; House, AA; Urquhart, BL; Velenosi, TJ1
Ayala, PY; Badger, J; Hausheer, FH; Jair, K; Kochat, H; Leverett, BD; Logan, C; Nienaber, VL; Parker, AR; Petluru, PN; Sridhar, V1

Other Studies

5 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and cysteine

ArticleYear
Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cisplatin; Cysteine; Disulfides; Glutathione; Half-Life; Humans; Infusions, Intravenous; Kinetics; Mesna; Neoplasms; Paclitaxel; Sulfhydryl Compounds

2003
Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
    Biochemical pharmacology, 2004, Aug-01, Volume: 68, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Cysteine; Cytosol; Electrochemistry; Enzymes; Erythrocytes; Glutathione; Humans; Mesna; Protective Agents; Rats; Tissue Distribution

2004
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2

    Topics: Allosteric Regulation; Biocatalysis; CD13 Antigens; Cisplatin; Cysteine; Dipeptides; Glutathione; Glycine; Humans; Kidney Diseases; Kinetics; Mesna; Models, Biological; Protective Agents; Recombinant Proteins

2011
Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
    Amino acids, 2015, Volume: 47, Issue:3

    Topics: Animals; Cell Line; Cysteine; Female; Glutathione; Homocysteine; Humans; Kidney; Liver; Mesna; Mice; Oxidation-Reduction

2015
Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787.
    Molecules (Basel, Switzerland), 2015, Mar-18, Volume: 20, Issue:3

    Topics: Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Cysteine; Glutaredoxins; Homeodomain Proteins; Humans; Mass Spectrometry; Mesna; Models, Molecular; Peroxiredoxins; Protein Structure, Tertiary

2015